Suchergebnisse - "Yang, Freda"

PubPharm (9)

1

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

enthalten in: Allergy | 2022

von Diver, S. | Haldar, K. | McDowell, P. | +25

2

Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE)

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Yang, F. | Busby, J. | Heaney, L. | +10

CommentIn: J Allergy Clin Immunol Pract. 2022 Dec;10(12):3343. - PMID 36496220

3

Anti-IL-5 therapies for asthma

enthalten in: The Cochrane database of systematic reviews | 2022

von Farne, H. | Wilson, A. | Milan, S. | +3

UpdateOf: Cochrane Database Syst Rev. 2017 Sep 21;9:CD010834. - PMID 28933516

4

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

enthalten in: Allergy | 2022

von Diver, S. | Haldar, K. | McDowell, P. | +24

5

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study) : a prospective observational study

enthalten in: The Lancet. Respiratory medicine | 2021

von McDowell, P. | Diver, S. | Yang, F. | +41

6

Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy

enthalten in: ERJ open research | 2021

von Butler, C. | McMichael, A. | Honeyford, K. | +10

7

Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry

enthalten in: The journal of allergy and clinical immunology. In practice | 2021

von Yang, F. | Busby, J. | Heaney, L. | +15

8

The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse : the virus or the lockdown?

enthalten in: ERJ open research | 2021

von Smith, S. | Busby, J. | Heaney, L. | +28

CommentIn: Transpl Int. 2021 Nov;34(11):2122-2137. - PMID 34378227

9

Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma : a multicentre, single-blind, parallel group, randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Heaney, L. | Busby, J. | Hanratty, C. | +48

CommentIn: Lancet Respir Med. 2021 Jan;9(1):3-5. - PMID 32918891

1
[1]